Fjarde Ap-fonden’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-197,516
Closed -$19.6M 634
2019
Q3
$19.6M Sell
197,516
-1,000
-0.5% -$95K 0.26% 86
2019
Q2
$18.4M Sell
198,516
-3,500
-2% -$332K 0.24% 92
2019
Q1
$19.1M Buy
202,016
+37,776
+23% +$3.3M 0.24% 87
2018
Q4
$10.5M Sell
164,240
-28,800
-15% -$2.13M 0.18% 112
2018
Q3
$17.3M Sell
193,040
-17,263
-8% -$1.53M 0.25% 83
2018
Q2
$16.7M Sell
210,303
-10,562
-5% -$877K 0.25% 87
2018
Q1
$19.7M Buy
220,865
+4,276
+2% +$410K 0.3% 70
2017
Q4
$22.6M Buy
216,589
+33,351
+18% +$3.76M 0.34% 63
2017
Q3
$26.7M Buy
183,238
+4,037
+2% +$550K 0.51% 38
2017
Q2
$23.3M Buy
179,201
+24,030
+15% +$2.94M 0.47% 38
2017
Q1
$19.3M Sell
155,171
-11,094
-7% -$1.33M 0.46% 40
2016
Q4
$19.2M Sell
166,265
-16,442
-9% -$1.83M 0.45% 44
2016
Q3
$19.1M Buy
182,707
+3,144
+2% +$340K 0.42% 46
2016
Q2
$17.7M Buy
179,563
+941
+0.5% +$97.3K 0.41% 50
2016
Q1
$17.9M Buy
178,622
+21,932
+14% +$2.26M 0.41% 50
2015
Q4
$18.8M Sell
156,690
-564
-0.4% -$65.3K 0.49% 43
2015
Q3
$17M Sell
157,254
-12,538
-7% -$1.56M 0.47% 47
2015
Q2
$19.7M Sell
169,792
-9,853
-5% -$1.13M 0.47% 46
2015
Q1
$20.7M Sell
179,645
-10,703
-6% -$1.28M 0.48% 48
2014
Q4
$21.3M Sell
190,348
-13,679
-7% -$1.44M 0.46% 44
2014
Q3
$19.3M Sell
204,027
-18,899
-8% -$1.71M 0.41% 50
2014
Q2
$19.1M Sell
222,926
-16,380
-7% -$1.25M 0.38% 54
2014
Q1
$16.7M Buy
239,306
+10,296
+4% +$815K 0.33% 70
2013
Q4
$19.3M Sell
229,010
-17,836
-7% -$1.41M 0.4% 53
2013
Q3
$19M Sell
246,846
-18,794
-7% -$1.32M 0.41% 54
2013
Q2
$15.5M Buy
+265,640
New +$16M 0.32% 66

Other funds holding CELG

Fjarde Ap-fonden's CELG Position: Q4 2019 in Review

Fjarde Ap-fonden sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 197,516 shares — an estimated $19.6M sold.

Fjarde Ap-fonden first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $26.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Fjarde Ap-fonden reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Fjarde Ap-fonden sold 197,516 Celgene Corp shares in Q4 2019, an estimated $19.6M.
  • Fjarde Ap-fonden first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Fjarde Ap-fonden's Celgene Corp position peaked at $26.7M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Fjarde Ap-fonden's 13F filing for Q4 2019, filed 10 Feb 2020.